Journal Report

Safety and Risk of Pharmacotherapy

Download PDF
Journal Information
Journal Title
Safety and Risk of Pharmacotherapy
Publisher
FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
ISSN
2312-7821
E-ISSN
2619-1164
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025
2024
2023
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Combination Therapy with Antipsychotics: Effects on Platelet Hemostasis and Systemic Inflammation in Schizophrenic Spectrum Disorders (Review)
N. A. Shnayder, E. Guseinov, Z. T. Taygibova et al.
2026-10-22
DOI: 10.30895/2312-7821-2026-583
Safety of Antibacterial Agents in Liver Transplantation: A Review of Pharmacokinetic and Pharmacodynamic Aspects
A. A. Isakova, R. B. Alikhanov, O. Yu. Gasieva et al.
2026-10-7
DOI: 10.30895/2312-7821-2026-586
Luspatercept in Myelodysplastic Syndrome: A Review of Efficacy and Safety Data
O. S. Levchenkova, V. E. Novikov, V. V. Vorobieva et al.
2026-10-4 Vol. 14 Issue 3 Pages 331-345
DOI: 10.30895/2312-7821-2026-14-3-331-345
Qualitative and Quantitative Assessment of Pharmacotherapy in a Medical Organization: A Pilot Study
T. I. Kolesnik, L. A. Gabbasova, E. P. Pavlikova et al.
2026-10-4 Vol. 14 Issue 3 Pages 320-330
DOI: 10.30895/2312-7821-2026-561
Pharmacoepidemiology of Treatment-Resistant Schizophrenia: Structure and Frequency of Adverse Drug Reactions in Real-World Clinical Practice
D. N. Sosin, E. A. Mozol, D. A. Golovina et al.
2026-10-4 Vol. 14 Issue 3 Pages 302-319
DOI: 10.30895/2312-7821-2026-556
Tirzepatide and Semaglutide in Type 2 Diabetes Mellitus and Obesity: A Comparative Assessment of Efficacy and Safety (Review)
E. M. Eliseeva, A. A. Druzhinina, A. A. Chistokhina
2026-10-4 Vol. 14 Issue 3 Pages 249-262
DOI: 10.30895/2312-7821-2026-14-3-249-262
Self-Medication with Tirzepatide for Weight Loss Resulting in Life-Threatening Conditions: A Clinical Case
E. V. Dovgan, I. V. Andreeva, S. Yu. Anisimova et al.
2026-10-4 Vol. 14 Issue 3 Pages 278-289
DOI: 10.30895/2312-7821-2026-577
Bacteriophages in Generalized Infections: A Review of Global Experience and Prospects for Phage Therapy
R. L. Parfenuk, R. E. Kazakov, Z. V. Durmanova
2026-10-4 Vol. 14 Issue 3 Pages 290-301
DOI: 10.30895/2312-7821-2026-14-3-290-301
Active Development Portfolio for Obesity Pharmacotherapy: An Analysis of Data from the ClinicalTrials.gov Registry
R. I. Yagudina, D. S. Tsapko
2026-10-4 Vol. 14 Issue 3 Pages 263-277
DOI: 10.30895/2312-7821-2026-14-3-263-277
Personalization and Safety of Pharmacotherapy: Evolution of Approaches to the Treatment of Obesity and Eating Disorders
D. B. Nikityuk, A. V. Pogozheva, R. N. Alyautdin
2026-10-4 Vol. 14 Issue 3 Pages 243-248
DOI: 10.30895/2312-7821-2026-14-3-243-248
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 25, 2026 15:58